HuGE Literature Finder
Records
1
-
8
| Effects of STAT3 polymorphisms and pharmacokinetics on the clinical outcomes of gefitinib treatment in patients with EGFR-mutation positive non-small cell lung cancer. Journal of clinical pharmacy and therapeutics 2020 May . Yokota Hayato, Sato Kazuhiro, Sakamoto Sho, Okuda Yuji, Asano Mariko, Takeda Masahide, Nakayama Katsutoshi, Miura Masato |
| Recurrent PTPRT/JAK2 mutations in lung adenocarcinoma among African Americans. Nature communications 2019 Dec 10 (1): 5735. Mitchell Khadijah A, Nichols Noah, Tang Wei, Walling Jennifer, Stevenson Holly, Pineda Marbin, Stefanescu Roxana, Edelman Daniel C, Girvin Andrew T, Zingone Adriana, Sinha Sanju, Bowman Elise, Rossi Emily L, Arauz Rony F, Jack Zhu Yuelin, Lack Justin, Weingartner Elizabeth, Waterfall Josh, Pine Sharon R, Simmons John, Meltzer Paul, Ryan Bríd |
| STAT3 rs4796793 contributes to lung cancer risk and clinical outcomes of platinum-based chemotherapy. International journal of clinical oncology 2019 Jan . Gong Wei-Jing, Ma Li-Yun, Hu Lei, Lv Yong-Ning, Huang Hong, Xu Jia-Qiang, Huang Dan-Dan, Liu Rui-Jie, Han Yong, Zhang Yu, Shi Shao-Jun, Wu San-L |
| Single nucleotide polymorphisms of the NF-?B and STAT3 signaling pathway genes predict lung cancer prognosis in a Chinese Han population. Cancer genetics 2015 Jun 208 (6): 310-8. He Fei, Yang Rong, Li Xiao-Yu, Ye Chao, He Bao-Chang, Lin Tao, Xu Xiao-Qin, Zheng Ling-Ling, Luo Wen-Ting, Cai L |
| STAT3 rs3816769 polymorphism correlates with gene expression level and may predispose to nonsmall cell lung cancer: a preliminary study. Polskie Archiwum Medycyny Wewn?trznej 2013 123 (12): 672-9. Doma?ska Daria, Antczak Adam, Pastuszak-Lewandoska Dorota, Górski Pawe?, Kordiak Jacek, Czarnecka Karolina, Migdalska-S?k Monika, Nawrot Ewa, Kisza?kiewcz Justyna, Brzezia?ska E |
| Correlation of activated STAT3 expression with clinicopathologic features in lung adenocarcinoma and squamous cell carcinoma. Molecular diagnosis & therapy 2011 Dec 15 (6): 347-52. Jiang Richeng, Jin Ziliang, Liu Zhujun, Sun Leina, Wang Liuchun, Li K |
| STAT3 gene polymorphisms and susceptibility to non-small cell lung cancer. Genetics and molecular research : GMR 2011 10 (3): 1856-65. Jiang B, Zhu Z Z, Liu F, Yang L J, Zhang W Y, Yuan H H, Wang J G, Hu X H, Huang |
| Epidermal growth factor receptor mutations in non-small cell lung cancer influence downstream Akt, MAPK and Stat3 signaling. Journal of cancer research and clinical oncology 2009 May 135 (5): 723-30. Zimmer Sebastian, Kahl Philip, Buhl Theresa M, Steiner Susanne, Wardelmann Eva, Merkelbach-Bruse Sabine, Buettner Reinhard, Heukamp Lukas |
- Page last reviewed:Oct 1, 2021
- Page last updated:Oct 20, 2021
- Content source: